Lymph node metastasis-associated transcript 1 (LNMAT1), alternatively named DUXAP9 or LINC01296, was identified as a candidate oncogene in bladder cancer in the same study by Seitz et al. [101] that discovered the oncogenic properties of BLACAT2. Chen et al. [104] showed that LNMAT1 is a nuclear-enriched lncRNA that is overexpressed in LN-positive bladder cancer and is associated with lymphatic metastasis and poor prognosis. This evidence concerns the gene DUXAP9 and urinary bladder cancer.